Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

NCT00541008 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
92
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UNICANCER